Michael Pešl

1.3k total citations
36 papers, 454 citations indexed

About

Michael Pešl is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michael Pešl has authored 36 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Michael Pešl's work include Bladder and Urothelial Cancer Treatments (13 papers), Urinary and Genital Oncology Studies (9 papers) and Renal cell carcinoma treatment (6 papers). Michael Pešl is often cited by papers focused on Bladder and Urothelial Cancer Treatments (13 papers), Urinary and Genital Oncology Studies (9 papers) and Renal cell carcinoma treatment (6 papers). Michael Pešl collaborates with scholars based in Czechia, Saudi Arabia and Netherlands. Michael Pešl's co-authors include Viktor Soukup, J Dvořáček, J Dušková, Pavel Dundr, C Povýšil, Marko Babjuk, Tomáš Hanuš, Jean de la Rosette, Otakar Čapoun and Evelyne C. C. Cauberg and has published in prestigious journals such as Urology, Anticancer Research and Pathology & Oncology Research.

In The Last Decade

Michael Pešl

23 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pešl Czechia 12 329 99 84 83 74 36 454
Yu‐Ching Wei Taiwan 11 233 0.7× 127 1.3× 105 1.3× 117 1.4× 67 0.9× 33 454
Vikas Mehta United States 12 226 0.7× 127 1.3× 84 1.0× 78 0.9× 80 1.1× 43 406
Dharam Ramnani United States 9 141 0.4× 174 1.8× 52 0.6× 47 0.6× 43 0.6× 12 377
Ryan P. McCarthy United States 6 219 0.7× 124 1.3× 101 1.2× 69 0.8× 22 0.3× 8 409
Nilda González-Roibón United States 14 293 0.9× 273 2.8× 91 1.1× 215 2.6× 44 0.6× 26 561
Ashanti Zampa Italy 13 157 0.5× 52 0.5× 70 0.8× 88 1.1× 57 0.8× 21 517
Keisuke Shigeta Japan 12 290 0.9× 148 1.5× 133 1.6× 73 0.9× 71 1.0× 52 482
A Cancrini Italy 13 305 0.9× 50 0.5× 81 1.0× 46 0.6× 130 1.8× 35 417
Sabina Sevcenco Austria 13 126 0.4× 297 3.0× 63 0.8× 147 1.8× 73 1.0× 39 512
Naoya Niwa Japan 11 147 0.4× 102 1.0× 82 1.0× 87 1.0× 21 0.3× 46 321

Countries citing papers authored by Michael Pešl

Since Specialization
Citations

This map shows the geographic impact of Michael Pešl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pešl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pešl more than expected).

Fields of papers citing papers by Michael Pešl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pešl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pešl. The network helps show where Michael Pešl may publish in the future.

Co-authorship network of co-authors of Michael Pešl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pešl. A scholar is included among the top collaborators of Michael Pešl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pešl. Michael Pešl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pešl, Michael, et al.. (2021). Vícečetná laparoskopická resekce u pacientky s mnohočetnými tumory solitární ledviny. 25(1). 13–14. 2 indexed citations
2.
Macek, Petr, et al.. (2019). Laparoscopic partial nephrectomy: a comprehensive evaluation of single-centre perioperative outcomes. 23(3). 221–229. 1 indexed citations
3.
Soukup, Viktor, Otakar Čapoun, Michael Pešl, et al.. (2018). Placental Growth Factor in Bladder Cancer Compared to the Diagnostic Accuracy and Prognostic Performance of Vascular Endothelial Growth Factor A. Anticancer Research. 38(1). 239–246. 7 indexed citations
4.
Sobotka, Roman, et al.. (2017). Experience with the prostate health index in daily clinical practice. 21(4). 284–288.
5.
6.
Pešl, Michael, Viktor Soukup, Marko Babjuk, et al.. (2015). Význam stanovení močové hladiny TATI (tumour associated trypsin inhibitor) pro diagnostiku a prognózu tumorů močového měchýře. 19(1). 44–50. 1 indexed citations
7.
Soukup, Viktor, Marta Kalousová, Otakar Čapoun, et al.. (2015). Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma. Urologia Internationalis. 95(1). 56–64. 33 indexed citations
8.
Soukup, Viktor, et al.. (2014). Intravesical therapy of urinary bladder tumours. 18(2). 85–93.
9.
Soukup, Viktor, J Dušková, Michael Pešl, et al.. (2014). The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study. Urologia Internationalis. 92(2). 150–156. 24 indexed citations
10.
Pešl, Michael, et al.. (2011). Hodnocení významu klinicko-patologických prognostických faktorů u nádorů močového měchýře neinfiltrujících svalovinu. 15(4). 222–228.
11.
Dundr, Pavel, Michael Pešl, C Povýšil, Lenka Bauerová, & Viktor Soukup. (2009). Primary Large Cell Neuroendocrine Carcinoma of the Kidney. Pathology & Oncology Research. 16(1). 139–142. 10 indexed citations
12.
13.
14.
Pešl, Michael, et al.. (2007). Traumatická ruptura hydronefrotické ledviny. Urologie pro praxi. 8(2). 81–82.
15.
Soukup, Viktor, et al.. (2007). [The p53 positivity in non-tumor mucosa in patients with superficial urinary bladder cancer].. PubMed. 146(1). 63–7. 2 indexed citations
16.
Dundr, Pavel, Michael Pešl, C Povýšil, et al.. (2007). Pigmented microcystic chromophobe renal cell carcinoma. Pathology - Research and Practice. 203(8). 593–597. 9 indexed citations
17.
Pešl, Michael, et al.. (2006). kazuistika nemocné s oboustranným iatrogenním poraněním močovodů. Urologie pro praxi. 6(3). 122–123. 1 indexed citations
18.
Babjuk, M., Viktor Soukup, J. Mareš, et al.. (2006). Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder. Urology. 67(4). 756–761. 13 indexed citations
19.
Pešl, Michael, et al.. (2005). Prostatický specifický antigen a odvozené parametry. Urologie pro praxi. 5(2). 59–63. 2 indexed citations
20.
Dundr, Pavel, Michael Pešl, C Povýšil, Ivana Vítková, & J Dvořáček. (2003). Large Cell Neuroendocrine Carcinoma of the Urinary Bladder with Lymphoepithelioma-like Features. Pathology - Research and Practice. 199(8). 559–563. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu‐Ching Wei Breakdown of academic impact, for papers by Vikas Mehta Breakdown of academic impact, for papers by Dharam Ramnani Breakdown of academic impact, for papers by Ryan P. McCarthy Breakdown of academic impact, for papers by Nilda González-Roibón Breakdown of academic impact, for papers by Ashanti Zampa Breakdown of academic impact, for papers by Keisuke Shigeta Breakdown of academic impact, for papers by A Cancrini Breakdown of academic impact, for papers by Sabina Sevcenco Breakdown of academic impact, for papers by Naoya Niwa
Rankless by CCL
2026